Statements of Cash Flows - USD ($)	1 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Cash Flows from Operating Activities:
Net income (loss)	$ (970)	$ 6,936,302
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Income from investments held in Trust Account		(7,353)
Formation cost paid by Sponsor in exchange for issuance of Class B common stock	970
Other expense relating to fair value exceeding amount paid for warrants		387,728
Change in fair value of derivative warrant liabilities		(9,138,360)
Offering costs allocated to warrants		703,509
Changes in current assets and liabilities:
Prepaid expenses		(294,306)
Accounts payable and accrued expenses		507,636
Franchise tax payable		200,050
Net cash used in operating activities		(704,794)
Cash Flows from Investing Activities:
Investment of cash in Trust Account		(221,647,440)
Net cash used in investing activities		(221,647,440)
Cash Flows from Financing Activities:
Proceeds from initial public offering, net of costs		217,214,490
Proceeds from private placement		6,682,950
Proceeds from issuance of promissory note to related party		240,000
Repayment of promissory note to related party		(240,000)
Payment of deferred offering costs		(640,100)
Net cash used in financing activities		223,257,340
Net change in cash		905,106
Cash, beginning of the period
Cash, end of the period		905,106
Supplemental disclosure of cash flow information:
Deferred underwriting commissions charged to additional paid in capital		7,757,660
Initial classification of derivative warrant liabilities		18,751,655
Forfeiture of Class B common stock		21
Deferred Offering costs paid by Sponsor in exchange for issuance of Class B common stock	24,030
Accrued deferred offering costs	$ 25,000